A detailed history of Nomura Asset Management CO LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 201,503 shares of EW stock, worth $14.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
201,503
Previous 277,460 27.38%
Holding current value
$14.9 Million
Previous $25.6 Million 48.12%
% of portfolio
0.04%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$59.7 - $93.78 $4.53 Million - $7.12 Million
-75,957 Reduced 27.38%
201,503 $13.3 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $2.02 Million - $2.26 Million
23,967 Added 9.45%
277,460 $25.6 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $801,929 - $1.06 Million
11,055 Added 4.56%
253,493 $24.2 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $11 Million - $13.8 Million
-177,692 Reduced 42.29%
242,438 $18.5 Million
Q3 2023

Nov 03, 2023

SELL
$69.28 - $93.38 $3.07 Million - $4.14 Million
-44,371 Reduced 9.55%
420,130 $29.1 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $6.17 Million - $7.15 Million
75,748 Added 19.48%
464,501 $43.8 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $6.83 Million - $7.77 Million
91,967 Added 30.99%
388,753 $32.2 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $420,728 - $538,630
-6,160 Reduced 2.03%
296,786 $22.1 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $666,126 - $867,654
8,087 Added 2.74%
302,946 $25 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $3.97 Million - $5.89 Million
45,883 Added 18.43%
294,859 $28 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $517,446 - $651,325
5,075 Added 2.08%
248,976 $29.3 Million
Q4 2021

Feb 01, 2022

BUY
$106.37 - $130.68 $12.6 Million - $15.5 Million
118,797 Added 94.96%
243,901 $31.6 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $377,370 - $450,124
3,667 Added 3.02%
125,104 $14.2 Million
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $307,860 - $384,678
3,672 Added 3.12%
121,437 $12.6 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $239,816 - $276,362
3,048 Added 2.66%
117,765 $9.85 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $331,207 - $421,482
4,620 Added 4.2%
114,717 $10.5 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $136,194 - $177,240
-2,027 Reduced 1.81%
110,097 $8.79 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $4.28 Million - $5.72 Million
74,329 Added 196.66%
112,124 $7.75 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $190,667 - $294,678
3,638 Added 10.65%
37,795 $7.13 Million
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $73,851 - $84,552
-1,030 Reduced 2.93%
34,157 $7.97 Million
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $165,015 - $202,227
2,681 Added 8.25%
35,187 $7.74 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $1.01 Million - $1.17 Million
-18,130 Reduced 35.8%
32,506 $6.01 Million
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $106,267 - $142,126
-2,219 Reduced 4.2%
50,636 $9.69 Million
Q4 2018

Feb 12, 2019

BUY
$46.41 - $56.94 $65,902 - $80,854
1,420 Added 2.76%
52,855 $8.1 Million
Q3 2018

Nov 07, 2018

BUY
$45.7 - $58.03 $964,909 - $1.23 Million
21,114 Added 69.63%
51,435 $8.95 Million
Q2 2018

Aug 03, 2018

BUY
$42.45 - $51.3 $35,233 - $42,579
830 Added 2.81%
30,321 $4.41 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $40,239 - $51,340
1,082 Added 3.81%
29,491 $4.12 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $421,327 - $491,153
-12,469 Reduced 30.5%
28,409 $3.2 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $1.48 Million - $1.59 Million
40,878
40,878 $4.47 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.